Drugs / Fluzone® Quadrivalent Influenza Vaccine, No Preservative
Fluzone® Quadrivalent Influenza Vaccine, No Preservative
also known as
Fluzone Quadrivalent, No Preservative
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02539108 | Aug → Dec 2015 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT02222870 | Aug → Dec 2014 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Quadrivalent Influenza Vaccine, No Preservative | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02539108 ↗ |
| Known as | Fluzone Quadrivalent, No Preservative | “Fluzone® Quadrivalent, No Preservative” NCT02222870 ↗ |
| Modality | Vaccine | “2014-2015 formulation of Fluzone Quadrivalent vaccine” NCT02222870 ↗ |
| Route | Intramuscular | “0.25 mL, Intramuscular (Pediatric Dose, 2014-2015 formulation)” NCT02222870 ↗ |